Cargando…

Inhibition of in vitro Ebola infection by anti-parasitic quinoline derivatives

There continues to be no approved drugs for the treatment of Ebola virus disease (EVD). Despite a number of candidate drugs showing limited efficacy in vitro and/or in non-human primate studies, EVD continues to plaque certain areas of Africa without any efficacious treatments yet available. Recentl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goyal, Shawn, Binnington, Beth, McCarthy, Stephen D.S., Desmaële, Didier, Férrié, Laurent, Figadère, Bruno, Loiseau, Philippe M., Branch, Donald R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268155/ https://www.ncbi.nlm.nih.gov/pubmed/32528661 http://dx.doi.org/10.12688/f1000research.22352.1

Ejemplares similares

Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection
por: Veljkovic, Veljko, et al.
Publicado: (2015)

The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
por: Loiseau, Philippe M., et al.
Publicado: (2022)

Lauflumide (NLS-4) Is a New Potent Wake-Promoting Compound
por: Luca, Gianina, et al.
Publicado: (2018)

Scope and Limitations of Exploiting the Ability of the Chemosensitizer NV716 to Enhance the Activity of Tetracycline Derivatives against Pseudomonas aeruginosa
por: Draveny, Margot, et al.
Publicado: (2023)

Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus
por: Cui, Qinghua, et al.
Publicado: (2018)

Mechanism of increased efficacy of recombinant Fc‐μTP‐L309C compared to IVIg to ameliorate mouse immune thrombocytopenia
por: Lewis, Bonnie J.B., et al.
Publicado: (2021)

Verotoxin A Subunit Protects Lymphocytes and T Cell Lines against X4 HIV Infection in Vitro
por: Shi, Pei Lin, et al.
Publicado: (2012)

Comprehensive Clinical and Laboratory Follow-up of a Female Patient With Ebola Virus Disease: Sierra Leone Ebola Virus Persistence Study
por: Liu, William J, et al.
Publicado: (2019)

The chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia
por: Branch, Donald R., et al.
Publicado: (2022)

IDSA Ebola Summary—August 2014
por: Murray, Barbara E., et al.
Publicado: (2014)

Clinical Evaluation of QuickNavi(TM)-Ebola in the 2018 Outbreak of Ebola Virus Disease in the Democratic Republic of the Congo
por: Makiala, Sheila, et al.
Publicado: (2019)

A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus
por: McCarthy, Stephen D. S., et al.
Publicado: (2016)

Risk in the “Red Zone”: Outcomes for Children Admitted to Ebola Holding Units in Sierra Leone Without Ebola Virus Disease
por: Fitzgerald, F, et al.
Publicado: (2017)

Check and Report Ebola (CARE) Hotline: The User Perspective of an Innovative Tool for Postarrival Monitoring of Ebola in the United States
por: McCarthy, Ilana Olin, et al.
Publicado: (2017)

Ebola Virus Ribonucleic Acid Detection in Semen More Than Two Years After Resolution of Acute Ebola Virus Infection
por: Fischer, William A, et al.
Publicado: (2017)

Added Value of an Anti-Ebola Serology for the Management of Clinically Suspected Ebola Virus Disease Patients Discharged as Negative in an Epidemic Context
por: Nkuba-Ndaye, Antoine, et al.
Publicado: (2022)

End of the Ebola virus outbreak: time to reinforce the African health system and improve preparedness capacity
por: Mulinge, Ivy, et al.
Publicado: (2016)

Ebola Hemorrhagic Fever and the Current State of Vaccine Development
por: Hong, Joo Eun, et al.
Publicado: (2014)

Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
por: Reynard, Olivier, et al.
Publicado: (2015)

Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral Fluid
por: Lambe, Teresa, et al.
Publicado: (2016)

Dilemmas in Managing Pregnant Women With Ebola: 2 Case Reports
por: Caluwaerts, Séverine, et al.
Publicado: (2016)

Gregarine parasites are adapted to mosquito winter diapause
por: Martin, Edwige, et al.
Publicado: (2022)

Isoagglutinin‐reduced immunoglobulin retains efficacy in mouse models of immune thrombocytopenia and rheumatoid arthritis and is less likely to cause intravenous immunoglobulin–associated hemolysis
por: Cen, Selena Y., et al.
Publicado: (2019)

The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking
por: Harrison, Angela R., et al.
Publicado: (2021)

Knowledge and risk perceptions of the Ebola virus in the United States
por: Rolison, Jonathan J., et al.
Publicado: (2015)

Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses
por: Gunn, Bronwyn M, et al.
Publicado: (2020)

In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease
por: Veljkovic, Veljko, et al.
Publicado: (2015)

In silico analysis suggests interaction between Ebola virus and the extracellular matrix
por: Veljkovic, Veljko, et al.
Publicado: (2015)

Exposure to Ebola Virus and Risk for Infection with Malaria Parasites, Rural Gabon
por: Abbate, Jessica L., et al.
Publicado: (2020)

Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors
por: Mouscadet, Jean-François, et al.
Publicado: (2010)

Ebola virus disease: an update for anesthesiologists and intensivists
por: Funk, Duane J., et al.
Publicado: (2014)

Ethical concerns for anesthesiologists during an Ebola threat
por: Klar, Gregory, et al.
Publicado: (2015)

Antimalarial Activity of Artefenomel Against Asexual Parasites and Transmissible Gametocytes During Experimental Blood-Stage Plasmodium vivax Infection
por: Collins, Katharine A, et al.
Publicado: (2020)

Transcriptomic and functional resources for the small hive beetle Aethina tumida, a worldwide parasite of honey bees
por: Tarver, Matthew R., et al.
Publicado: (2016)

Regulatory and Operational Complexities of Conducting a Clinical Treatment Trial During an Ebola Virus Disease Epidemic
por: Rojek, Amanda M, et al.
Publicado: (2018)

Rapid Detection of Ebola Virus with a Reagent-Free, Point-of-Care Biosensor
por: Baca, Justin T., et al.
Publicado: (2015)

TriQuinoline
por: Adachi, Shinya, et al.
Publicado: (2019)

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection
por: Wauquier, Nadia, et al.
Publicado: (2010)

Interpretation of Negative Molecular Test Results in Patients With Suspected or Confirmed Ebola Virus Disease: Report of Two Cases
por: Edwards, Jeffrey K., et al.
Publicado: (2015)

Disability Among Ebola Survivors and Their Close Contacts in Sierra Leone: A Retrospective Case-Controlled Cohort Study
por: Jagadesh, Soushieta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p5f04fl4d3he3uaua8hkh401im